104 related articles for article (PubMed ID: 5323770)
1. Catecholamines in neuropsychiatric states.
Kety SS
Pharmacol Rev; 1966 Mar; 18(1):787-98. PubMed ID: 5323770
[No Abstract] [Full Text] [Related]
2. [Molecular organicity of abnormal behaviors and mental disorders].
Laborit H
Agressologie; 1972; 13(2):83-91. PubMed ID: 4342791
[No Abstract] [Full Text] [Related]
3. [Biochemical approaches to mental diseases].
Henry MP
Bord Med; 1972 Mar; 5(5):455-69. PubMed ID: 5071670
[No Abstract] [Full Text] [Related]
4. [Biological psychiatry. 1) The dopamine-acetylcholine equilibrium model].
Adèr JP
TVZ; 1988 Jan; 42(1):13-6. PubMed ID: 2895504
[No Abstract] [Full Text] [Related]
5. Current status of catecholamines and their implication in various diseases.
Uddin M; Green P
Manit Med Rev; 1967 Dec; 47(10):561-6. PubMed ID: 4867045
[No Abstract] [Full Text] [Related]
6. Biochemical aspects of schizophrenia.
Lewis ME
Essays Neurochem Neuropharmacol; 1980; 4():1-67. PubMed ID: 6104597
[No Abstract] [Full Text] [Related]
7. [Biogenic amines in various internal and psychiatric diseases].
Schrammowa H; Rybakowski J
Psychiatr Pol; 1972; 6(4):477-81. PubMed ID: 4561368
[No Abstract] [Full Text] [Related]
8. Metabolomics tools for identifying biomarkers for neuropsychiatric diseases.
Quinones MP; Kaddurah-Daouk R
Neurobiol Dis; 2009 Aug; 35(2):165-76. PubMed ID: 19303440
[TBL] [Abstract][Full Text] [Related]
9. [Neuropsychiatric diseases and amino acid metabolism].
Kakimoto Y
Nihon Rinsho; 1966 Jan; 24(1):23-30. PubMed ID: 5336582
[No Abstract] [Full Text] [Related]
10. New gene targets related to schizophrenia and other psychiatric disorders: enzymes, binding proteins and transport proteins involved in phospholipid and fatty acid metabolism.
Horrobin DF; Bennett CN
Prostaglandins Leukot Essent Fatty Acids; 1999 Mar; 60(3):141-67. PubMed ID: 10359017
[TBL] [Abstract][Full Text] [Related]
11. [Study of phenol excretion in clinical psychiatry. II. Total, free, conjugated, acid, volatile phenols and vanyl-mandelic acid].
Enkin M; Treuil J; Bécache A; Revol L
Encephale; 1966; 55(5):391-451. PubMed ID: 6008261
[No Abstract] [Full Text] [Related]
12. [Schizophrenia and catecholamines].
Chouinard G
Union Med Can; 1975 Jun; 104(6):885-9. PubMed ID: 1224408
[No Abstract] [Full Text] [Related]
13. Catecholamine metabolism. From molecular understanding to clinical diagnosis and treatment. Overview.
Boulton AA; Eisenhofer G
Adv Pharmacol; 1998; 42():273-92. PubMed ID: 9327897
[No Abstract] [Full Text] [Related]
14. [A fascinating prospect: psychiatric biology].
Fazio C
Minerva Med; 1972 Feb; 63(13):755-6. PubMed ID: 5013641
[No Abstract] [Full Text] [Related]
15. [Abnormalities of catecholamine metabolism in Parkinson's disease (author's transl)].
Nagatsu T
Tanpakushitsu Kakusan Koso; 1981 Aug; 26(11):1781-8. PubMed ID: 6117927
[No Abstract] [Full Text] [Related]
16. [Symposium: metabolism in neurogical disorders. 1. Parkinsonism. 1-(1). Metabolic disturbance in Parkinsonism].
Tsukada Y; Yamada K; Tsubaki T
Nihon Naika Gakkai Zasshi; 1972 Sep; 61(9):1126-30. PubMed ID: 4674038
[No Abstract] [Full Text] [Related]
17. [The therapeutic use of L-DOPA in Parkinson's disease. Biochemical, pharmacological and clinical considerations].
Morselli PL; Rizzo M; Tognoni G
Recenti Prog Med; 1970 Feb; 48(2):97-124. PubMed ID: 5467589
[No Abstract] [Full Text] [Related]
18. The TiPS/TINS Lecture. Catecholamines: from gene regulation to neuropsychiatric disorders.
Mallet J
Trends Neurosci; 1996 May; 19(5):191-6. PubMed ID: 8723206
[TBL] [Abstract][Full Text] [Related]
19. The role of catecholamines in specific psychiatric disorders.
Friedhoff AJ; Van Winkle E
Res Publ Assoc Res Nerv Ment Dis; 1966; 43():366-70. PubMed ID: 5330548
[No Abstract] [Full Text] [Related]
20. [Neuromelanine and mental diseases: dysmetabolic pathogenetic theory of schizophrenia. (New trends of research)].
Bonifacio A; Volpe S
Riv Patol Nerv Ment; 1967; 88(1):45-82. PubMed ID: 5621266
[No Abstract] [Full Text] [Related]
[Next] [New Search]
